Company Overview

Globus Medical, Inc. is a U.S.-based medical device company focused on the musculoskeletal healthcare market, with a primary emphasis on spinal surgery, orthopedic trauma, joint reconstruction, and enabling technologies. The company develops and commercializes implantable devices, biologics, navigation systems, robotic-assisted surgery platforms, and procedural solutions used by surgeons and healthcare systems. Globus Medical operates within the broader medical technology and orthopedic devices industry and generates revenue primarily through sales of spinal implants, orthopedic products, enabling technologies, and related surgical solutions.

The company was founded in 2003 by spine industry veterans including David C. Paul and grew rapidly through product innovation and surgeon-focused design. Over time, it expanded from a spine-focused manufacturer into a broader musculoskeletal technology company through internal development and acquisitions, most notably the merger with NuVasive, Inc. completed in 2023. Globus Medical is positioned competitively through its integrated product ecosystem, strong surgeon relationships, vertically integrated manufacturing capabilities, and focus on procedural efficiency and enabling technologies such as navigation and robotics.

Business Operations

Globus Medical organizes its operations primarily around its Musculoskeletal Solutions business, which includes spinal implants, trauma products, joint reconstruction systems, biologics, and procedural technologies. Revenue is derived largely from product sales to hospitals and ambulatory surgery centers, supported by a direct sales force and distributor network. The company’s portfolio includes products for cervical, thoracolumbar, and minimally invasive spine procedures, as well as orthopedic trauma fixation and robotic-assisted surgical systems. Following the acquisition of NuVasive, Inc., the company significantly expanded its implant portfolio, surgeon customer base, and international commercial infrastructure.

The company operates domestically across the United States and internationally in regions including Europe, Asia-Pacific, Latin America, and the Middle East. Globus Medical controls important technologies and assets including the ExcelsiusGPS robotic navigation platform, advanced imaging and navigation software, biologics manufacturing capabilities, and implant design technologies. The company also maintains manufacturing and operational facilities in the United States and abroad. Strategic relationships with healthcare providers, surgeons, and research institutions support product development and adoption, while subsidiaries and acquired entities contribute to expanded market reach and product diversification.

Strategic Position & Investments

Globus Medical’s strategic direction centers on expanding its musculoskeletal platform through technology integration, procedural innovation, and global scale. A major strategic milestone was the acquisition of NuVasive, Inc., which materially increased the company’s market share in spine surgery and broadened its international footprint. The company continues investing in robotic-assisted surgery, navigation systems, imaging integration, and digitally enabled surgical workflows intended to improve procedural accuracy and operating room efficiency.

The company has also focused on growth initiatives in orthopedic trauma, motion preservation, biologics, and outpatient surgical markets. Investments in research and development remain significant relative to peers in the spinal device sector, reflecting a strategy built around product innovation and surgeon adoption. Globus Medical has emphasized integrated procedural solutions that combine implants, navigation, robotics, and data-driven technologies into a unified surgical ecosystem. Public filings and investor communications consistently identify enabling technologies and global commercial expansion as key long-term priorities.

Geographic Footprint

Globus Medical is headquartered in Audubon, Pennsylvania, and maintains operations across multiple global regions. The company’s largest revenue base remains the United States, though international markets have become increasingly important following the combination with NuVasive, Inc. The company sells products through direct sales organizations and distributors across North America, Europe, Asia-Pacific, Latin America, and selected markets in the Middle East and Africa.

Its international presence includes commercial offices, distribution infrastructure, and operational facilities supporting surgeon training, product development, and customer service. The expanded global platform following the NuVasive transaction increased the company’s access to international spinal implant markets and diversified revenue sources beyond the United States. Globus Medical’s products are used in hospitals, specialty surgical centers, and academic institutions across numerous healthcare systems worldwide.

Leadership & Governance

Globus Medical’s leadership team combines experience in orthopedic devices, spinal surgery technologies, manufacturing, and healthcare operations. The company’s governance structure includes executive leadership oversight and a board focused on operational execution, product innovation, and long-term shareholder value. Following the integration with NuVasive, Inc., leadership has emphasized scale efficiencies, technology integration, and expansion of the company’s musculoskeletal platform.

Key executives include:

• Keith W. Pfeil – President and Chief Executive Officer
• Keith A. Sullivan – Chief Financial Officer
• Dan Scavilla – Chief Commercial Officer
• David C. Paul – Executive Chairman
• Scott Lutz – Chief Human Resources Officer
• Joseph Gill – Senior Vice President, General Counsel and Corporate Secretary

Leadership communications and public filings indicate a strategic philosophy centered on surgeon-driven innovation, operational execution, and integrated procedural technologies. The company’s governance and strategic priorities are regularly outlined in SEC filings, annual reports, and investor presentations.